Terminal airway occlusion by hypersecretive mucus is a major manifestation in chronic obstructive pulmonary disease (COPD). In the cystic fibrosis lung, a genotype of COPD, hyperactive ENaC has already been proved to be a fundamental mechanism for dehydration of airway, in turn, causes impaired mucociliary clearance. However, little is known about the expression and regulation of ENaC channels in human COPD lung. The balance between protease and antiprotease in the airway mucus is crucial. It has been confirmed that reduction of the activity of 11-antitrypsin, a very important antiprotease inhibitor to inhibit elastase, an emphysema-causing enzyme released by neutrophils. Based on our previous and new exciting preliminary results, we hypothesize that ENaC expression is up-regulated in distal bronchoalveolar epithelial cells mediated by a protease-antiprotease imbalance in COPD lungs. Our two Specific Aims include: 1) to quantitatively investigate the expression patterns and subcellular locations of four ENaC subunits (1, 2, 3, and 4 ENaC) in the lung specimens collected from COPD;2) to investigate the expression levels and enzymatic activities of protease/antiprotease and their interactions with ENaC in the lung tissues in COPD. Results of these studies may provide a proof-of-concept for the correlation of ENaC expression, lung function, and clinicopathology in human COPD and discover dehydration of airway surface fluid as a novel target for developing new therapeutic strategies to combat COPD.
Chronic obstructive pulmonary disease (COPD) is characterized by terminal airway occlusion. Over expression of a salt transport, namely, ENaC in mice results in COPD-like lung. Importantly, inhibition of ENaC will significantly improve their lung function. However, ENaC expression in human COPD lung has not been studied. We will examine ENaC subunit expression and their association with clinical severity. Our results will definitely provide answers to the question if ENaC is over expressed or not in human COPD lung.
| Bai, Yichun; Liu, Yang; Su, Zhenlei et al. (2018) Gene editing as a promising approach for respiratory diseases. J Med Genet 55:143-149 |
| Li, Yue; Chang, Jianjun; Cui, Yong et al. (2017) Novel mechanisms for crotonaldehyde-induced lung edema. Oncotarget 8:83509-83522 |
| Ji, Hong-Long; Nie, Hong-Guang; Chang, Yongchang et al. (2016) CPT-cGMP Is A New Ligand of Epithelial Sodium Channels. Int J Biol Sci 12:359-66 |
| Cui, Yong; Li, Huiming; Wu, Sihui et al. (2016) Formaldehyde impairs transepithelial sodium transport. Sci Rep 6:35857 |
| Bhandary, Yashodhar P; Shetty, Shwetha K; Marudamuthu, Amarnath S et al. (2015) Plasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A virus infection-induced lung injury. PLoS One 10:e0123187 |
| Ji, Hong-Long; Zhao, Runzhen; Komissarov, Andrey A et al. (2015) Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites. J Biol Chem 290:5241-55 |
| Wang, Wen; Ji, Hong-Long (2015) Epithelial Sodium and Chloride Channels and Asthma. Chin Med J (Engl) 128:2242-9 |
| Chen, Zaixing; Zhao, Runzhen; Zhao, Meimi et al. (2014) Regulation of epithelial sodium channels in urokinase plasminogen activator deficiency. Am J Physiol Lung Cell Mol Physiol 307:L609-17 |
| Zhao, Runzhen; Liang, Xinrong; Zhao, Meimi et al. (2014) Correlation of apical fluid-regulating channel proteins with lung function in human COPD lungs. PLoS One 9:e109725 |
| Ji, Hong-Long; Zhao, Run-Zhen; Chen, Zai-Xing et al. (2012) ? ENaC: a novel divergent amiloride-inhibitable sodium channel. Am J Physiol Lung Cell Mol Physiol 303:L1013-26 |
Showing the most recent 10 out of 17 publications
